It seems as though Dr. Habets has successfully treated an ME patient with low doses teclistamab. Much more cost effective than daratumumab apparently (< 1000€ per treatment course). This is the German maverick oncologist that's also treated ME patients successfully with daratumumab in the past...
Highlights
76 bacterial species of 15 genera across healthy, COVID-19-positive, and recovered individuals
Higher abundance of opportunistic intracellular bacteria in recovered group
Higher microbial abundance within antigen-presenting cells of COVID-19 patients
Differential microbial abundance...
I've just come across a patent from Fluge and Mella which looks like it was updated/published in March 2021 entitled 'Method for the treatment of chronic fatigue syndrome using an inhibitory or cytotoxic agent against plasma cells'.
The description of the patent is a long read...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.